IPO registrations (S-1, F-1) · Registrants

CytRx Oncology Corp

SEC CIK: 1337223 · filings on EDGAR ↗
Name on the registration: Innovive Pharmaceuticals, Inc.
Former names: Innovive Pharmaceuticals, Inc. (2005–2008)
Registration: Form S-1, first filed 2006-08-07, last 2007-08-01; 2 initial registrations, 1 amendment
Outcome: Declared effective 2006-08-10
Industry (SIC): Biological Products, (No Diagnostic Substances) 2836
Incorporated in: DE
Business address: 555 MADISON AVENUE, 25TH FLOOR, New York, NY 10022
EIN: 74-3123261
EDGAR entity type: operating
Insiders and CEO pay: CytRx Oncology Corp on the corporate pages

Offering terms

Shares offered: 8,516,528
Listing: under the symbol IVPH

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

On this site

Form 5500 plan sponsor: INNOVIVE PHARMACEUTICALS, INC EXACT (EIN (EXACT))
SEC filer: CytRx Oncology Corp EXACT (CIK (EXACT))

Filings 5

Filed	Form	What it is	Name as filed	EDGAR
2006-08-07	S-1	S-1 (registration)	Innovive Pharmaceuticals, Inc.	0001193125-06-162575 ↗
2006-08-10	EFFECT	EFFECT (declared effective)	Innovive Pharmaceuticals, Inc.	9999999995-06-001168 ↗
2007-05-24	S-1	S-1 (registration)	Innovive Pharmaceuticals, Inc.	0000950144-07-005156 ↗
2007-08-01	S-1/A	S-1/A (amendment)	Innovive Pharmaceuticals, Inc.	0000950144-07-007095 ↗
2007-08-09	EFFECT	EFFECT (declared effective)	Innovive Pharmaceuticals, Inc.	9999999995-07-003226 ↗

Prospectus pages read 1

Filed	Form	Read as	Range	Price	Shares	Proceeds	Listing	Underwriters	What was found	Document
2007-08-01	S-1/A	registration statement		$3.75	8,516,528	$31,936,980	IVPH	0	primary document; price sentence, shares headline, proceeds computed	document ↗

Officers, directors and large holders Forms 3, 4 and 5

Insider	Role	Title	Filings	Years
Craig Adam R	Officer	VP and Chief Medical Officer	6	2006–2007
Kelly Steven	Director,Officer	President and CEO	4	2006–2008
KNOX JOHN	Officer	Treasurer	2	2006
Lipschutz Lester E	TenPercentOwner		1	2006
Nippon Shinyaku Co Ltd	TenPercentOwner		1	2006
Poma Eric E	Officer	VP - Business Development	5	2006–2008
ROCAMBOLI STEPHEN	Director,Officer	Secretary	2	2006
WEISER MICHAEL	Director		2	2006
ROSENWALD LINDSAY A MD	TenPercentOwner		2	2006–2008
Pfaffle Antony	Director		3	2006–2008
LOBELL J JAY	Director		4	2006–2008
Herskowitz Neil	Director		6	2006–2008
Jester J Gregory	Officer	Chief Financial Officer	4	2006–2008
DECARO ANGELO	Director		2	2007–2008
Frost Philip	Director		3	2007–2008

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

Record	Name as filed	Where	Dataset	Matched by
SEC filer	CytRx Oncology Corp		SEC filers (EDGAR)	CIK (EXACT)
Form 5500 plan sponsor	INNOVIVE PHARMACEUTICALS, INC			EIN (EXACT)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Biological Products, (No Diagnostic Substances), NY first:

More with this interest.

In other datasets, the same topic (Health) in NY:

Nonprofit: AABR FOUNDATION INC (Nonprofits (IRS Form 990))

Interests: Biological Products, (No Diagnostic Substances) · Health